The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review

The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review

Abstract Background The COVID-19 pandemic led to an unprecedented relaxation of restrictions on take-home doses in opioid agonist treatment (OAT). We conducted a mixed methods systematic review to explore the impact of these changes on program effectiveness and client experiences in OAT. Methods The...

Full description

Bibliographic Details
Main Authors: Alison Adams, Sarin Blawatt, Tianna Magel, Scott MacDonald, Julie Lajeunesse, Scott Harrison, David Byres, Martin T. Schechter, Eugenia Oviedo-Joekes
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Substance Abuse Treatment, Prevention, and Policy
Subjects:
Substance use
Opioid use disorder
Opioid agonist treatment
COVID-19
Online Access:https://doi.org/10.1186/s13011-023-00564-9

Internet

https://doi.org/10.1186/s13011-023-00564-9

Similar Items